期刊文献+

冠心病危险评分模型的最新研究进展 被引量:4

Research Progress of Risk Stratification Model in Coronary Heart Disease
下载PDF
导出
摘要 近年来,冠心病的诊治处理已从传统的"诊断→治疗"模式转换为"诊断→危险度分层→治疗"的模式。因此,危险度分层和预后判断,是现代冠心病诊疗的关键与核心。目前有多种危险分层模型用于临床,以临床资料、实验室指标、冠状动脉解剖特点为主要内容进行评分,为冠心病患者的预后评估及分层治疗提供临床参考依据。现就几个侧重点不同的危险分层模型进行综述。 Recently,the diagnosis and treatment of coronary heart disease from the traditional"diagnosis→treatment"mode is converted to "diagnosis→risk stratification→treatment"mode. Therefore,risk statification and prognostic judgment,is the key and core of modern diagnosis and treatment of coronary heart disease. There are many kinds of risk stratification model used in clinic. Mostly,it uses clinical data,laboratory index,the characteristics of coronary artery anatomy as the main content of the score,to provide clinical reference for the evaluation of prognosis and stratified for treating patients with coronary heart disease. This article want to made an overview of several different emphases risk stratified model.
作者 刘娜 邢波
出处 《心血管病学进展》 CAS 2015年第4期405-409,共5页 Advances in Cardiovascular Diseases
基金 海南省卫生厅科研项目(琼卫科教〔2014〕30号)
关键词 冠心病 危险评分模型 预后判断 coronary heart disease risk stratified model prognosis
  • 相关文献

参考文献22

  • 1Ong AT,Serruys PW, Mohr FW,et al. The SYNergy between percutaneous coro- nary intervention with TAXus and cardiac surgery(SYNTAX) study:design, ra tinale,and run-in phase[ J]. Am Heart J,2006,151 (6) :1194-1204.
  • 2van der Wall EE. ESC Congress 2008 in Munich:Hot news from Hot lines[ J]. Neth Heart J,2008,16( 11 ):367-368.
  • 3Sianos G, Morel MA, Kappetein AP, eL al. TILe SYNTAX Score : an angiographic tool grading the complexity of coronary artery disease [ J ]. Emolntervention, 2005,1 (2):219-227.
  • 4Fox KA, Goodman SG, Klein W, et al. Global registry [J]. Eur Heart J,2002,23(15):1177-1189.
  • 5Granger CB, Golberg R J, Dabbous OH, et al. Predictors of hospital mortality in the global registry of acute coronary events [ J ]. Arch Intern Med, 2003,163 (19) :2345-2353.
  • 6孙艺红,胡大一,闰明珠.非ST段抬高急性冠状动脉综合征的预后危险因素与危险评分[J].中国循环杂志,2006,21(1):8-11. 被引量:34
  • 7de Arajo Gonqalves P, Ferreira J, Aguim C, et al. TIMI, PURSUIT, and GRACE risk scores: sustained prognostic value and interaction with revascular- ization in NSTE-ACS [J]. Eur Heart J,2005,26(9):865-872.
  • 8Pahnefini T, Genereux P, Caixeta A, et al. A new scot for risk stratification of patients with acute coronary syndromes undergoing peutaneous coronmy inter- vention: the ACUITY-PCI (Acute Catheterization and Urgent Intervention Tri- age Strategy-Percutaneous Coronary Intervention) risk score[ J ]. JACC Cmdio- vasc Interv, 2012,5 ( 11 ) :1108-1116.
  • 9Chen SL, Chen JP, Mintz G, et al. Comparison between tile NERS(New Risk Stratification) score and the SYNTAX (Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery) score in outcome prediction for unprotected left main stenting[ J]. JACC Cardiovasc Interv,2010,3(6) :632- 641.
  • 10Nam CW, Mangiacapra F, Entjes R, et al. Functional SYNTAX sco for risk assessment in multivessel coronary artery disease[J]. J Am Coll Cardio1,2011, 58(12):1211-1218.

二级参考文献17

  • 1Antman EM, Cohen M, Bernink PJLM,et al. The TIMI risk score for unstable angina/non-ST elevation MI. JAMA ,2000,284:835-842.
  • 2Granger CB, Goldberg RJ, Dabbous OH ,et al. For the global registry of acute coronary events investigators. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med,2003,163:2345-2353.
  • 3Diderholm E, Andren B, Frostfeldt G, et al. The prognostic and therapeutic implications of increased troponin T levels and ST depression in unstable coronary artery disease: the FRISC Ⅱ invasive troponin T electrocardiogram substudy, Am Heart J, 2002,143: 760-767.
  • 4AI Suwaidi J, Reddan DN, Williams K, et al. Prognostic implications of abnormalities in renal function in patients with acute coronary syndromes. Circulation, 2002,106:974-980.
  • 5Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions. J Am Coil Cardiol, 2002,39 : 1113-1119.
  • 6Shlipak MG, Heidenreich PA, Noguchi ti, et al. Association of renal in-sufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med,2002 ,137 :555-562.
  • 7Kannel WB, Wolf PA, Castelli WP, et al. Fibrinogen and risk of cardiovascular disease: the Framingham Study. JAMA, 1987,258 : 1183-1186.
  • 8Stampfer MJ, Malinow MR, Willett WC, et al. A prospective study of plasma homocyst(e)ine and risk of myocardial infarction in US physicians. JAMA, 1992,268 : 877 -881.
  • 9Bostom AG, Shemin D, Lapane KL, et al. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients: a matched case-control study. Atherosclerosis, 1996, 125:91-101.
  • 10McCullough PA, Soman SS, Shah SS, et al. Risks associated with renal dysfunction in the coronary care unit, J Am Coil Cardiol, 2000,35:679-684.

共引文献38

同被引文献51

引证文献4

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部